SCHEMBL2373677

SCHEMBL2373677

C=Cc1ccc(N(C)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PAX8 Q06710 1/20 0.46
TGM2 P21980 1/20 0.40
BRD4 O60885 2/20 0.40
CREBBP Q92793 1/20 0.40
RAB9A P51151 3/20 0.38
NPC1 O15118 2/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NOTUM Q6P988 1/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 1/20 0.35
HSD17B3 P37058 1/20 0.34
MIF P14174 1/20 0.34
MT-CO2 P00403 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8018111 0.86 PAX8 (0.55) PAX8TGM2BRD4CREBBPRAB9A
SCHEMBL3261042 0.85 CYP2A6 (0.48) PAX8TGM2BRD4CREBBPRAB9A
SCHEMBL31335398 0.82 PAX8 (0.40) PAX8TGM2BRD4CREBBPRAB9A
SCHEMBL2641765 0.81 PAX8 (0.49) PAX8TGM2BRD4CREBBPRAB9A
SCHEMBL470988 0.81 PAX8 (0.44) PAX8BRD4CREBBPRAB9AKDM4E
SCHEMBL4031315 0.80 HSD17B3 (0.45) PAX8BRD4CREBBPMAPTMEN1
SCHEMBL4028881 0.80 THRB (0.47) PAX8RAB9ANPC1KDM4EMAPT
SCHEMBL14384381 0.80 PAX8 (0.50) PAX8BRD4CREBBPRAB9AMAPT
SCHEMBL3364970 0.80 PAX8 (0.50) PAX8BRD4CREBBPRAB9ANPSR1
SCHEMBL24448783 0.78 NPSR1 (0.58) PAX8BRD4CREBBPRAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111499544-B Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2022-12-02 CN claimed
CN-111499544-A Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2020-08-07 CN claimed
CN-102526765-A Abeta plaque developing agent and preparation method thereof ZHENGZHOU TETRANOV PHARMACEUTICAL TECHNOLOGY CO LTD 2012-07-04 CN claimed
CN-111499570-B Synthesis method of AV-45 intermediate 中国医学科学院放射医学研究所 2023-05-16 CN disclosed
CN-111499544-B Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2022-12-02 CN disclosed
CN-111499544-B Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2022-12-02 CN disclosed
CN-111499544-B Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2022-12-02 CN disclosed
CN-111499544-A Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2020-08-07 CN disclosed
CN-111499544-A Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2020-08-07 CN disclosed
CN-111499544-A Synthetic method for preparing N-Boc-N-methyl-4-aminostyrene by one-pot method 中国医学科学院放射医学研究所 2020-08-07 CN disclosed
CN-111499570-A Synthetic method of AV-45 intermediate 中国医学科学院放射医学研究所 2020-08-07 CN disclosed
CN-102526765-A Abeta plaque developing agent and preparation method thereof ZHENGZHOU TETRANOV PHARMACEUTICAL TECHNOLOGY CO LTD 2012-07-04 CN disclosed
EP-1999109-B1 STYRYLPYRIDINE DERIVATIVES AND THEIR USE FOR BINDING AND IMAGING AMYLOID PLAQUES UNIV PENNSYLVANIA (US) 2011-12-28 EP disclosed
EP-2363391-A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques The Trustees of The University of Pennsylvania (US) 2011-09-07 EP disclosed
EP-2363392-A1 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques The Trustees of The University of Pennsylvania (US) 2011-09-07 EP disclosed
US-7687052-B2 radiolabeling; neurodegenerative diseases THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2010-03-30 US disclosed
US-20090123369-A1 Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2009-05-14 US disclosed
US-20080253967-A1 Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2008-10-16 US disclosed
US-20080253967-A1 Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2008-10-16 US disclosed
US-20080038195-A1 radiolabeling; neurodegenerative diseases THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080253967-A1 Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques APP, APBA1, HSPBP1 PAX8 2621/4885TGM2 2249/4885BRD4 483/4885
US-20080038195-A1 radiolabeling; neurodegenerative diseases APP, PSEN1, HTT PAX8 4795/4885TGM2 1392/4885BRD4 460/4885
US-20090123369-A1 Styrylpyridine Derivatives and Their Use for Binding and Imaging Amyloid Plaques APP, APBA1, PSEN1 PAX8 4418/4885TGM2 1683/4885BRD4 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.